Savara
SVRA
#5436
Rank
HK$10.29 B
Marketcap
HK$50.58
Share price
0.46%
Change (1 day)
82.62%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -HK$0.91 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.75 Billion a decrease over its 2023 earnings that were of -HK$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.91 Billion20.82%
2024 -HK$0.75 Billion75.29%
2023 -HK$0.43 Billion43.38%
2022 -HK$0.3 Billion-11.31%
2021 -HK$0.34 Billion-13.3%
2020 -HK$0.39 Billion-36.53%
2019 -HK$0.61 Billion13.76%
2018 -HK$0.54 Billion105.54%
2017 -HK$0.27 Billion34.11%
2016 -HK$0.2 Billion-37.43%
2015 -HK$0.32 Billion38.81%
2014 -HK$0.23 Billion33.62%
2013 -HK$0.17 Billion38.49%
2012 -HK$0.13 Billion24.59%
2011 -HK$96.88 Million-36.5%
2010 -HK$0.16 Billion-3.14%
2009 -HK$0.16 Billion-23.28%
2008 -HK$0.21 Billion8.52%
2007 -HK$0.19 Billion-34.14%
2006 -HK$0.29 Billion184.43%
2005 -HK$0.11 Billion90.75%
2004 -HK$52.95 Million190.35%
2003 -HK$18.24 Million11.64%
2002 -HK$16.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA